- Tacrolimus, which was recently approved by the FDA as a
transplantation medicine, is anticipated to boost the category in
the years to come
- The Asia Pacific region is
a major region for transplant drug monitoring assay. The growing
emphasis on organ donation is what is driving the market in
Asia Pacific
ALBANY, N.Y.,
June 28,
2022 /PRNewswire/ -- The value of the global
transplant drug monitoring assay market stood at US$ 198.0 Mn in 2021. The global market is
anticipated to rise at CAGR of 11.0% during the forecast period,
from 2022 to 2031. The global transplant drug monitoring assay
market is also expected to attain valuation surpassing US$ 542 Mn by 2031. In order to keep blood
and plasma concentrations of immunosuppressants within the
acceptable therapeutic limits, healthcare providers must use
therapeutic drug monitoring (TDM) in transplant medicine. TDM
controls concentrations to ensure that they are neither too
high or too low, reducing the likelihood of toxicity or
rejection, as appropriate. These factors are likely to drive market
demand for transplant drug monitoring assay in the years to
come.
In order to assist in patient monitoring, top firms in the
healthcare sector provide a wide range of immunosuppressant drug
monitoring (ISD) tests, including those for everolimus,
cyclosporine, tacrolimus, and mycophenolic acid. In the coming
years, firms in the transplant drug monitoring assay market is
likely to benefit financially from rising healthcare spending,
government reimbursement schemes, improved healthcare
infrastructure, and rising global per capita income.
The global market for transplant drug monitoring assay is
anticipated to expand significantly during the forecasted period.
The need for organ transplants is growing, R&D spending is
surging, and chronic liver and kidney disorders are becoming more
common, all of which contribute to this market expansion. For
companies in the global transplant drug monitoring assay market,
the rising demand for home-based therapeutic drug monitoring
and point-of-care therapeutic drug monitoring is projected to
present profitable prospects.
Request Brochure of Transplant Drug Monitoring Assay Market
Research Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84851
Key Findings of Market Report
- The global population is aging quickly, particularly in
affluent nations like Japan,
Germany, and the US. The need for
organ transplants as well as replacements is being driven by an
increase in the prevalence of chronic illnesses of the pancreas,
kidney, heart, and liver, as well as blood disorders like aplastic
anemia and leukemia. The market for transplant medication
monitoring assays is anticipated to grow as a result.
- As a result of government organizations' activities, more
people are becoming organ donors worldwide. Through educational
initiatives, financial support, and practical programs and
policies, several governmental entities in developing and developed
nations promote organ donation. The global transplant drug
monitoring assay market expansion is also attributed to government
encouragement for organ donation.
- Depending on product type, the equipment segment accounted for
a sizable portion of the global market in 2021. The category is one
of the key market segments in transplant drug monitoring assay and
is anticipated to expand quickly throughout the projection period.
Mid-to-high volume laboratories can adapt their operations to
increase productivity and cut costs with the help of immunoassay
analyzers and clinical chemistry analyzers. This equipment offers
laboratories all around the world dependability and effectiveness
that has been field-tested, and it has great onboard parameters
throughput.
Request for Analysis of COVID-19 Impact on Transplant Drug
Monitoring Assay Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84851
Global Transplant Drug Monitoring Assay Market: Growth
Drivers
- In terms of technology, the chromatography-MS category is
likely to expand rapidly in the years to come and is expected to
have prominent market share for transplant drug monitoring
assay. The category is anticipated to grow at a CAGR of 12.2%
during the forecast timeframe. The segment's expansion can be
attributed to the global increase in demand for organ
transplants.
- In 2021, North America held a
significant percentage of the global transplant drug monitoring
assay market and is likely to offer largest opportunity for
transplant drug monitoring assay. The supremacy of North America can be attributed to surgical
methods, advancements in medical science, organ transplant success
rates, and immunosuppressive medications.
Get Exclusive PDF Sample Copy of Transplant Drug Monitoring
Assay Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84851
Global Transplant Drug Monitoring Assay Market: Key
Players
Some of the key market players are
- Hoffmann-La Roche Ltd.
- H.U. Group Holdings, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers AG
- Abbott Laboratories
Make an Enquiry Before Buying –
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84851
Global Transplant Drug Monitoring Assay Market:
Segmentation
Product
Technology
- Chromatography-MS
- Immunoassays
Drug
- Tacrolimus
- Methotrexate
- Cyclosporin
- Others
End-Use
- Hospital Laboratories
- Commercial & Private Laboratories
- Others
Modernization of healthcare in terms of both infrastructure
and services have pushed the healthcare industry to new heights,
Stay Updated with Latest Healthcare Industry Research
Reports by Transparency Market Research:
Organ Transplant Rejection Medications Market: The global organ
transplant rejection medications market is expected to reach a
value of ~US$ 6.3 Bn by the end of
the forecast period. High prevalence and increase in incidence of
several acute and chronic disorders worldwide are anticipated to
drive the global organ transplant rejection medications market.
Multiplex Detection Immunoassays Market: The global multiplex
detection immunoassays market is on the course to surpass
US$ 3.65 Bn mark by the end of 2030.
High prevalence and increase in incidence rate of chronic and
infectious diseases are projected to drive the global multiplex
detection immunoassays market in the near future.
Immunoassay Market: Rise in prevalence of such diseases is
likely to provide lucrative opportunities for the prominent market
players. In order to speed-up the diagnosis process, the companies
operating in the global immunoassay market are focusing on
development of novel immunoassay products.
Clinical Chemistry Analyzers Market: The global clinical
chemistry analyzers market was valued at ~US$ 11.3 Bn in 2018. The clinical chemistry
analyzers market is projected to expand at a CAGR of ~4% from 2019
to 2027.
Prepacked Chromatography Columns Market: Technology has been the
biggest aid for development in healthcare. As new diagnostic and
treatment methods come up, the pharmaceutical industry becomes
stronger. This has a positive impact on the markets that support
smooth operations of pharmaceutical companies. One such aiding
market for pharmaceuticals is the prepacked chromatography columns
market.
Cleanroom Consumables Market: The high demand for products such
as goggles, gloves, surgical masks, and gowns are translating into
income streams for stakeholders in the global cleanroom consumables
market. The ever-evolving nature of coronavirus strains has kept
medical professionals engaged in innovations for antiviral drugs
and vaccines.
PRP and PRF in Cosmetics Market: Changing lifestyles of the
people in developing regions, increase in per capita income, and
rise in awareness about beautification contribute to the growth of
the global PRP and PRF in cosmetics market.
Fetal Bovine Serum Market: Technological advancement in
biopharmaceuticals, innovative drug development process, and rising
applications in cost-effective personalized medicine are some of
the major factors driving the demand for biologics.
About Transparency Market Research
Transparency Market Research is a global market research company
providing business custom research and consulting services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision makers.
Our experienced team of Analysts, Researchers, and Consultants use
proprietary data sources and various tools & techniques to
gather and analyze information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our
YouTube Channel and hit subscribe for Future Update
- https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact Us:
Rohit
Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: http://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/transplant-drug-monitoring-assay-market-is-predicted-to-expand-at-a-cagr-of-11-0-during-the-forecast-period-notes-tmr-study-301576391.html
SOURCE Transparency Market Research